Detalles de la búsqueda
1.
Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study.
Clin Gastroenterol Hepatol
; 22(1): 154-163.e3, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442318
2.
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial.
Gastroenterology
; 163(5): 1294-1305.e3, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940251
3.
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial.
Clin Gastroenterol Hepatol
; 20(9): 2074-2082, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843987
4.
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.
Am J Gastroenterol
; 116(1): 134-141, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33177349
5.
Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease.
Clin Gastroenterol Hepatol
; 18(8): 1704-1718, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881273
6.
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease.
Clin Gastroenterol Hepatol
; 18(3): 637-646.e11, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128336
7.
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
Gastroenterology
; 154(5): 1343-1351.e1, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29317275
8.
Antimicrobial resistance of Helicobacter pylori in West Flanders - Belgium: an observational cross-sectional study.
Acta Clin Belg
; 77(2): 360-367, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502281
9.
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
Inflamm Bowel Dis
; 28(2): 208-217, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33783494
10.
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
Lancet
; 371(9613): 660-667, 2008 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-18295023
11.
Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.
Inflamm Bowel Dis
; 25(1): 156-162, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29920582
12.
Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study.
Patient Prefer Adherence
; 12: 1193-1202, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30013330
13.
Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS).
J Geriatr Oncol
; 9(2): 93-101, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133190
14.
Hemosuccus pancreaticus caused by rupture of a splenic artery pseudoaneurysm complicating chronic alcoholic pancreatitis: an uncommon cause of gastrointestinal bleeding.
Acta Gastroenterol Belg
; 78(4): 427-30, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26712055
15.
Alternative treatment options in colorectal cancer patients with 5-fluorouracil- or capecitabine-induced cardiotoxicity.
Clin Colorectal Cancer
; 12(1): 8-14, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23102544
16.
Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.
Inflamm Bowel Dis
; 19(10): 2111-7, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23883959
Resultados
1 -
16
de 16
1
Próxima >
>>